In the last 12 months, insiders at Pacira BioSciences, Inc. ($PCRX) filed 202 transactions with the SEC: 7 open-market purchases totaling $256,518 and 64 sales totaling $9,967,320. Net insider sentiment: net selling.
Pacira BioSciences, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- PACE GARY W (Director) — 8 transactions totaling $4,075,053
- WILLIAMS KRISTEN (Chief Administrative Officer) — 10 transactions totaling $1,466,036
- Cross Shawn (Chief Financial Officer) — 11 transactions totaling $1,447,439
- Lee Frank D. (Chief Executive Officer) — 8 transactions totaling $1,350,795
- Kronenfeld Mark A. (Director) — 10 transactions totaling $1,004,100
View all SEC Filings for Pacira BioSciences, Inc. (PCRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Froimson Mark | Director | S | Common Stock | 500 | $21.81 | 20,136.0000 | 45,729,000 | 2.42% | 0.00% |
| March 17, 2026 | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 3261 | $22.82 | 223,640.1750 | 45,729,000 | 1.44% | 0.01% |
| June 11, 2025 | Kronenfeld Mark A. | Director | A | Common Stock | 6163 | $0.00 | 31,065.0000 | 46,245,000 | 24.75% | 0.01% |
| Feb. 11, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | A | Common Stock | 54546 | $0.00 | 185,849.0000 | 45,729,000 | 41.54% | 0.12% |
| Feb. 11, 2026 | Cross Shawn | Chief Financial Officer | A | Common Stock | 49091 | $0.00 | 105,341.0000 | 45,729,000 | 87.27% | 0.11% |
| Feb. 11, 2026 | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 54546 | $0.00 | 226,901.1750 | 45,729,000 | 31.65% | 0.12% |
| Feb. 11, 2026 | Lee Frank D. | Chief Executive Officer | A | Common Stock | 261818 | $0.00 | 660,830.8410 | 45,729,000 | 65.62% | 0.57% |
| Feb. 11, 2026 | RIKER LAUREN | Senior Vice President, Finance | A | Common Stock | 19273 | $0.00 | 71,586.2420 | 45,729,000 | 36.84% | 0.04% |
| Feb. 11, 2026 | Teehan Brendan | Chief Commercial Officer | A | Common Stock | 51714 | $0.00 | 100,934.2680 | 45,729,000 | 105.07% | 0.11% |
| Feb. 2, 2026 | RIKER LAUREN | Senior Vice President, Finance | S | Common Stock | 4000 | $20.81 | 52,313.2420 | 45,729,000 | 7.10% | 0.01% |
| Jan. 30, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | F | Common Stock | 17134 | $20.54 | 144,440.0000 | 45,729,000 | 10.60% | 0.04% |
| Feb. 2, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | S | Common Stock | 13137 | $20.53 | 131,303.0000 | 45,729,000 | 9.10% | 0.03% |
| Jan. 30, 2026 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 6168 | $20.54 | 172,355.1750 | 45,729,000 | 3.46% | 0.01% |
| Jan. 30, 2026 | Teehan Brendan | Chief Commercial Officer | F | Common Stock | 5182 | $20.54 | 49,220.2680 | 45,729,000 | 9.53% | 0.01% |
| Jan. 30, 2026 | Lee Frank D. | Chief Executive Officer | F | Common Stock | 41488 | $20.54 | 399,012.8410 | 45,729,000 | 9.42% | 0.09% |
| Jan. 30, 2026 | RIKER LAUREN | Senior Vice President, Finance | F | Common Stock | 2751 | $20.54 | 56,313.2420 | 45,729,000 | 4.66% | 0.01% |
| Jan. 27, 2026 | Hirawat Samit | Director | A | Stock Option (Right to Buy) | 39291 | $0.00 | 39,291.0000 | 45,729,000 | 9999.99% | 0.09% |
| Dec. 31, 2025 | Teehan Brendan | Chief Commercial Officer | A | Common Stock | 402 | $10.76 | 54,402.2680 | 45,729,000 | 0.74% | 0.00% |
| Jan. 2, 2026 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 381 | $24.46 | 178,523.1750 | 45,729,000 | 0.21% | 0.00% |
| Jan. 2, 2026 | RIKER LAUREN | Senior Vice President, Finance | F | Common Stock | 159 | $24.46 | 60,480.2420 | 45,729,000 | 0.26% | 0.00% |
| Jan. 5, 2026 | RIKER LAUREN | Senior Vice President, Finance | S | Common Stock | 1416 | $24.24 | 59,064.2420 | 45,729,000 | 2.34% | 0.00% |
| Jan. 2, 2026 | Lee Frank D. | Chief Executive Officer | F | Common Stock | 9272 | $24.46 | 440,500.8410 | 45,729,000 | 2.06% | 0.02% |
| Dec. 9, 2025 | Cross Shawn | Chief Financial Officer | S | Common Stock | 15896 | $25.03 | 56,250.0000 | 45,729,000 | 22.03% | 0.03% |
| Dec. 10, 2025 | Cross Shawn | Chief Financial Officer | M | Common Stock | 9104 | $16.45 | 65,354.0000 | 45,729,000 | 16.18% | 0.02% |
| Dec. 10, 2025 | Cross Shawn | Chief Financial Officer | S | Common Stock | 9104 | $25.14 | 56,250.0000 | 45,729,000 | 13.93% | 0.02% |
| Dec. 9, 2025 | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 15896 | $0.00 | 184,104.0000 | 45,729,000 | 7.95% | 0.03% |
| Dec. 10, 2025 | Cross Shawn | Chief Financial Officer | M | Stock Option (Right to Buy) | 9104 | $0.00 | 175,000.0000 | 45,729,000 | 4.95% | 0.02% |
| Dec. 9, 2025 | Cross Shawn | Chief Financial Officer | M | Common Stock | 15896 | $16.45 | 72,146.0000 | 45,729,000 | 28.26% | 0.03% |
| Nov. 17, 2025 | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 3960 | $24.09 | 178,367.0090 | 45,729,000 | 2.17% | 0.01% |
| Nov. 10, 2025 | Cross Shawn | Chief Financial Officer | S | Common Stock | 12060 | $22.09 | 56,250.0000 | 45,729,000 | 17.65% | 0.03% |
| Oct. 31, 2025 | Cross Shawn | Chief Financial Officer | F | Common Stock | 6690 | $21.38 | 68,310.0000 | 45,729,000 | 8.92% | 0.01% |
| Sept. 4, 2025 | Ceesay Abraham | Director | S | Common Stock | 2354 | $27.19 | 9,039.0000 | 46,245,000 | 20.66% | 0.01% |
| Aug. 7, 2025 | BIGAL MARCELO | Director | S | Common Stock | 4912 | $23.67 | 11,393.0000 | 46,245,000 | 30.13% | 0.01% |
| Aug. 1, 2025 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 315 | $22.07 | 182,327.0090 | 46,245,000 | 0.17% | 0.00% |
| June 11, 2025 | YANG MICHAEL J. | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Ceesay Abraham | Director | A | Common Stock | 6163 | $0.00 | 11,393.0000 | 46,245,000 | 117.84% | 0.01% |
| June 11, 2025 | Ceesay Abraham | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Froimson Mark | Director | A | Common Stock | 6163 | $0.00 | 20,636.0000 | 46,245,000 | 42.58% | 0.01% |
| June 11, 2025 | Froimson Mark | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | BIGAL MARCELO | Director | A | Common Stock | 6163 | $0.00 | 16,305.0000 | 46,245,000 | 60.77% | 0.01% |
| June 11, 2025 | BIGAL MARCELO | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | YANG MICHAEL J. | Director | A | Common Stock | 6163 | $0.00 | 13,393.0000 | 46,245,000 | 85.24% | 0.01% |
| June 11, 2025 | CHRISTIE CHRISTOPHER | Director | A | Common Stock | 6163 | $0.00 | 16,654.0000 | 46,245,000 | 58.75% | 0.01% |
| June 11, 2025 | CHRISTIE CHRISTOPHER | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Young Alethia | Director | A | Common Stock | 6163 | $0.00 | 11,393.0000 | 46,245,000 | 117.84% | 0.01% |
| June 11, 2025 | Young Alethia | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Brege Laura | Director | A | Common Stock | 6163 | $0.00 | 23,715.0000 | 46,245,000 | 35.11% | 0.01% |
| June 11, 2025 | Brege Laura | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Kronenfeld Mark A. | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 11, 2025 | Kronenfeld Mark A. | Director | A | Common Stock | 9999 | $0.00 | 34,901.0000 | 46,245,000 | 40.15% | 0.02% |
| June 3, 2025 | RIKER LAUREN | Senior Vice President, Finance | F | Common Stock | 3374 | $26.40 | 65,142.3350 | 46,245,000 | 4.92% | 0.01% |
| June 3, 2025 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 5084 | $26.40 | 181,959.5110 | 46,245,000 | 2.72% | 0.01% |
| June 4, 2025 | WILLIAMS KRISTEN | Chief Administrative Officer | S | Common Stock | 14376 | $26.24 | 161,574.0000 | 46,245,000 | 8.17% | 0.03% |
| June 3, 2025 | WILLIAMS KRISTEN | Chief Administrative Officer | F | Common Stock | 6162 | $26.40 | 175,950.0000 | 46,245,000 | 3.38% | 0.01% |
| June 4, 2025 | RIKER LAUREN | Senior Vice President, Finance | S | Common Stock | 5578 | $26.21 | 59,564.0000 | 46,245,000 | 8.56% | 0.01% |
| Feb. 1, 2025 | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 93600 | $0.00 | 187,043.5110 | 46,245,000 | 100.17% | 0.20% |
| Feb. 1, 2025 | RIKER LAUREN | Senior Vice President, Finance | A | Common Stock | 30600 | $0.00 | 68,516.3350 | 46,245,000 | 80.70% | 0.07% |
| Feb. 4, 2025 | Teehan Brendan | Chief Commercial Officer | A | Stock Option (Right to Buy) | 99500 | $26.59 | 99,500.0000 | 46,245,000 | 9999.99% | 0.22% |
| Feb. 1, 2025 | Teehan Brendan | Chief Commercial Officer | A | Common Stock | 54000 | $0.00 | 54,000.0000 | 46,245,000 | 9999.99% | 0.12% |
| Feb. 1, 2025 | Lee Frank D. | Chief Executive Officer | A | Common Stock | 350000 | $0.00 | 448,409.0000 | 46,245,000 | 355.66% | 0.76% |
| Feb. 1, 2025 | WILLIAMS KRISTEN | Chief Administrative Officer | A | Common Stock | 79200 | $0.00 | 182,112.0000 | 46,245,000 | 76.96% | 0.17% |
| Jan. 2, 2025 | Lee Frank D. | Chief Executive Officer | F | Common Stock | 9375 | $18.33 | 98,409.0000 | 46,245,000 | 8.70% | 0.02% |
| Jan. 2, 2025 | RIKER LAUREN | Senior Vice President, Finance | F | Common Stock | 159 | $18.33 | 37,916.3350 | 46,245,000 | 0.42% | 0.00% |
| Dec. 31, 2024 | GAUGLER DARYL | Chief Operating Officer | A | Common Stock | 244 | $16.01 | 115,443.4890 | 46,269,000 | 0.21% | 0.00% |
| Jan. 6, 2025 | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 879 | $18.40 | 93,443.5110 | 46,245,000 | 0.93% | 0.00% |
| Jan. 2, 2025 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 371 | $18.33 | 94,322.5110 | 46,245,000 | 0.39% | 0.00% |
| Dec. 13, 2024 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 500 | $19.76 | 115,199.9520 | 46,269,000 | 0.43% | 0.00% |
| Nov. 4, 2024 | Cross Shawn | Chief Financial Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 46,269,000 | 9999.99% | 0.43% |
| Nov. 1, 2024 | Cross Shawn | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 75,000.0000 | 46,269,000 | 9999.99% | 0.16% |
| Sept. 13, 2024 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 500 | $12.86 | 115,699.9520 | 51,979,000 | 0.43% | 0.00% |
| Aug. 16, 2024 | BIGAL MARCELO | Director | P | Common Stock | 1512 | $13.25 | 10,142.0000 | 51,979,000 | 17.52% | 0.00% |
| Aug. 16, 2024 | Brege Laura | Director | P | Common Stock | 1000 | $12.81 | 17,552.0000 | 51,979,000 | 6.04% | 0.00% |
| Aug. 14, 2024 | YANG MICHAEL J. | Director | P | Common Stock | 2000 | $12.90 | 7,230.0000 | 51,979,000 | 38.24% | 0.00% |
| Aug. 12, 2024 | BIGAL MARCELO | Director | P | Common Stock | 3400 | $12.01 | 8,630.0000 | 51,979,000 | 65.01% | 0.01% |
| Aug. 12, 2024 | Lee Frank D. | Chief Executive Officer | P | Common Stock | 8264 | $12.10 | 107,784.0000 | 51,979,000 | 8.30% | 0.02% |
| Aug. 12, 2024 | BIGAL MARCELO | Director | P | Common Stock | 3400 | $12.01 | 8,630.0000 | 51,979,000 | 65.01% | 0.01% |
| Aug. 12, 2024 | Froimson Mark | Director | P | Common Stock | 1400 | $11.58 | 14,473.0000 | 51,979,000 | 10.71% | 0.00% |
| Aug. 2, 2024 | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 945 | $20.05 | 94,306.7460 | 51,979,000 | 0.99% | 0.00% |
| Aug. 1, 2024 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 305 | $20.75 | 95,251.7460 | 51,979,000 | 0.32% | 0.00% |
| June 28, 2024 | GAUGLER DARYL | Chief Operating Officer | A | Common Stock | 160 | $24.32 | 116,199.9520 | 51,979,000 | 0.14% | 0.00% |
| June 28, 2024 | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 437 | $24.32 | 99,306.7460 | 51,979,000 | 0.44% | 0.00% |
| July 1, 2024 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 914 | $28.46 | 98,392.7460 | 51,979,000 | 0.92% | 0.00% |
| July 2, 2024 | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 2836 | $28.25 | 95,556.7460 | 51,979,000 | 2.88% | 0.01% |
| June 12, 2024 | RIKER LAUREN | Senior Vice President, Finance | S | Common Stock | 3970 | $28.72 | 38,075.3350 | 51,979,000 | 9.44% | 0.01% |
| June 11, 2024 | SLONIN JONATHAN | Chief Medical Officer | S | Common Stock | 5012 | $28.57 | 44,569.4750 | 51,979,000 | 10.11% | 0.01% |
| June 12, 2024 | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 54300 | $0.00 | 98,869.4750 | 51,979,000 | 121.83% | 0.10% |
| June 12, 2024 | Kronenfeld Mark A. | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Kronenfeld Mark A. | Director | A | Common Stock | 5230 | $0.00 | 24,902.0000 | 51,979,000 | 26.59% | 0.01% |
| June 12, 2024 | Brege Laura | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Brege Laura | Director | A | Common Stock | 5230 | $0.00 | 16,552.0000 | 51,979,000 | 46.19% | 0.01% |
| June 13, 2024 | WILLIAMS KRISTEN | Chief Administrative Officer | S | Common Stock | 7452 | $28.38 | 102,912.0000 | 51,979,000 | 6.75% | 0.01% |
| June 12, 2024 | WILLIAMS KRISTEN | Chief Administrative Officer | A | Common Stock | 54300 | $0.00 | 110,364.0000 | 51,979,000 | 96.85% | 0.10% |
| June 12, 2024 | HASTINGS PAUL J | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 13, 2024 | HASTINGS PAUL J | Director | S | Common Stock | 880 | $28.38 | 12,724.0000 | 51,979,000 | 6.47% | 0.00% |
| June 12, 2024 | CHRISTIE CHRISTOPHER | Director | A | Common Stock | 5230 | $0.00 | 10,491.0000 | 51,979,000 | 99.41% | 0.01% |
| June 12, 2024 | CHRISTIE CHRISTOPHER | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | BIGAL MARCELO | Director | A | Common Stock | 5230 | $0.00 | 5,230.0000 | 51,979,000 | 9999.99% | 0.01% |
| June 12, 2024 | BIGAL MARCELO | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Reinhart Charles A. III | Chief Financial Officer | A | Common Stock | 12220 | $0.00 | 51,867.0000 | 51,979,000 | 30.82% | 0.02% |
| June 12, 2024 | YANG MICHAEL J. | Director | A | Common Stock | 5230 | $0.00 | 5,230.0000 | 51,979,000 | 9999.99% | 0.01% |
| June 12, 2024 | YANG MICHAEL J. | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Ceesay Abraham | Director | A | Common Stock | 5230 | $0.00 | 5,230.0000 | 51,979,000 | 9999.99% | 0.01% |
| June 12, 2024 | Ceesay Abraham | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | GAUGLER DARYL | Chief Operating Officer | A | Common Stock | 54300 | $0.00 | 117,039.5840 | 51,979,000 | 86.55% | 0.10% |
| June 12, 2024 | Froimson Mark | Director | A | Common Stock | 5230 | $0.00 | 13,073.0000 | 51,979,000 | 66.68% | 0.01% |
| June 13, 2024 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 1000 | $28.38 | 116,039.5840 | 51,979,000 | 0.85% | 0.00% |
| June 12, 2024 | Froimson Mark | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | Young Alethia | Director | A | Common Stock | 5230 | $0.00 | 5,230.0000 | 51,979,000 | 9999.99% | 0.01% |
| June 12, 2024 | Young Alethia | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 12, 2024 | HASTINGS PAUL J | Director | A | Common Stock | 5230 | $0.00 | 13,604.0000 | 51,979,000 | 62.46% | 0.01% |
| June 12, 2024 | RIKER LAUREN | Senior Vice President, Finance | A | Common Stock | 21360 | $0.00 | 42,045.3350 | 51,979,000 | 103.26% | 0.04% |
| June 3, 2024 | Reinhart Charles A. III | Chief Financial Officer | F | Common Stock | 2979 | $30.89 | 39,647.0000 | 51,979,000 | 6.99% | 0.01% |
| June 3, 2024 | WILLIAMS KRISTEN | Chief Administrative Officer | F | Common Stock | 3011 | $30.89 | 56,064.0000 | 51,979,000 | 5.10% | 0.01% |
| June 3, 2024 | GAUGLER DARYL | Chief Operating Officer | F | Common Stock | 2754 | $30.89 | 62,739.5840 | 51,979,000 | 4.20% | 0.01% |
| June 3, 2024 | SLONIN JONATHAN | Chief Medical Officer | F | Common Stock | 1615 | $30.89 | 49,581.4750 | 51,979,000 | 3.15% | 0.00% |
| June 3, 2024 | RIKER LAUREN | Senior Vice President, Finance | F | Common Stock | 1843 | $30.89 | 20,685.3350 | 51,979,000 | 8.18% | 0.00% |
| March 6, 2024 | PACE GARY W | Director | S | Common Stock | 1066 | $29.67 | 140,384.0000 | 51,979,000 | 0.75% | 0.00% |
| March 7, 2024 | PACE GARY W | Director | S | Common Stock | 28257 | $30.81 | 112,127.0000 | 51,979,000 | 20.13% | 0.05% |
| March 8, 2024 | PACE GARY W | Director | S | Common Stock | 90000 | $30.60 | 22,127.0000 | 51,979,000 | 80.27% | 0.17% |
| Feb. 5, 2024 | WILLIAMS KRISTEN | Chief Administrative Officer | A | Common Stock | 33700 | $0.00 | 59,075.0000 | 51,979,000 | 132.81% | 0.06% |
| Feb. 5, 2024 | GAUGLER DARYL | Chief Operating Officer | A | Common Stock | 33700 | $0.00 | 65,493.5840 | 51,979,000 | 106.00% | 0.06% |
| Jan. 2, 2024 | RIKER LAUREN | Senior Vice President, Finance | F | Common Stock | 159 | $32.00 | 22,528.3350 | 51,979,000 | 0.70% | 0.00% |
| Jan. 2, 2024 | SLONIN JONATHAN | Chief Medical Officer | A | Common Stock | 5000 | $0.00 | 51,196.4750 | 51,979,000 | 10.82% | 0.01% |
| Jan. 3, 2024 | SLONIN JONATHAN | Chief Medical Officer | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 51,979,000 | 9999.99% | 0.02% |
| Jan. 2, 2024 | Lee Frank D. | Chief Executive Officer | A | Common Stock | 99520 | $0.00 | 99,520.0000 | 51,979,000 | 9999.99% | 0.19% |
| Jan. 3, 2024 | Lee Frank D. | Chief Executive Officer | A | Stock Option (Right to Buy) | 692512 | $0.00 | 692,512.0000 | 51,979,000 | 9999.99% | 1.33% |
| Oct. 6, 2023 | Young Alethia | Director | A | Stock Option (Right to Buy) | 30967 | $0.00 | 30,967.0000 | 46,538,000 | 9999.99% | 0.07% |
| Oct. 6, 2023 | YANG MICHAEL J. | Director | A | Stock Option (Right to Buy) | 30967 | $0.00 | 30,967.0000 | 46,538,000 | 9999.99% | 0.07% |
| Oct. 6, 2023 | BIGAL MARCELO | Director | A | Stock Option (Right to Buy) | 30967 | $0.00 | 30,967.0000 | 46,538,000 | 9999.99% | 0.07% |
| Oct. 6, 2023 | Ceesay Abraham | Director | A | Stock Option (Right to Buy) | 30967 | $0.00 | 30,967.0000 | 46,538,000 | 9999.99% | 0.07% |
| Aug. 2, 2023 | WINSTON ROY | Chief Medical Officer | S | Common Stock | 509 | $34.88 | 52,440.3350 | 46,538,000 | 0.96% | 0.00% |
| July 5, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | S | Common Stock | 643 | $38.91 | 22,687.3350 | 46,538,000 | 2.76% | 0.00% |
| June 14, 2023 | Brege Laura | Director | A | Common Stock | 1775 | $0.00 | 11,322.0000 | 46,538,000 | 18.59% | 0.00% |
| June 14, 2023 | Brege Laura | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | S | Common Stock | 7 | $39.01 | 22,687.0000 | 46,538,000 | 0.03% | 0.00% |
| June 14, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 46,538,000 | 9999.99% | 0.05% |
| June 14, 2023 | Reinhart Charles A. III | Chief Financial Officer | A | Common Stock | 9000 | $0.00 | 42,626.0000 | 46,538,000 | 26.77% | 0.02% |
| June 14, 2023 | Reinhart Charles A. III | Chief Financial Officer | A | Stock Option (Right to Buy) | 22500 | $0.00 | 22,500.0000 | 46,538,000 | 9999.99% | 0.05% |
| June 14, 2023 | PACE GARY W | Director | A | Common Stock | 1775 | $0.00 | 141,450.0000 | 46,538,000 | 1.27% | 0.00% |
| June 14, 2023 | PACE GARY W | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | Kronenfeld Mark A. | Director | A | Common Stock | 1775 | $0.00 | 19,672.0000 | 46,538,000 | 9.92% | 0.00% |
| June 14, 2023 | Kronenfeld Mark A. | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | HASTINGS PAUL J | Director | A | Common Stock | 1775 | $0.00 | 8,374.0000 | 46,538,000 | 26.90% | 0.00% |
| June 14, 2023 | HASTINGS PAUL J | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | GAUGLER DARYL | Chief Operating Officer | A | Common Stock | 10000 | $0.00 | 31,539.0000 | 46,538,000 | 46.43% | 0.02% |
| June 14, 2023 | GAUGLER DARYL | Chief Operating Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 46,538,000 | 9999.99% | 0.05% |
| June 14, 2023 | Froimson Mark | Director | A | Common Stock | 1775 | $0.00 | 7,843.0000 | 46,538,000 | 29.25% | 0.00% |
| June 14, 2023 | Froimson Mark | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | CHRISTIE CHRISTOPHER | Director | A | Common Stock | 1775 | $0.00 | 5,261.0000 | 46,538,000 | 50.92% | 0.00% |
| June 14, 2023 | CHRISTIE CHRISTOPHER | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | S | Common Stock | 5773 | $38.52 | 22,694.0000 | 46,538,000 | 20.28% | 0.01% |
| June 14, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | S | Common Stock | 586 | $37.47 | 28,467.0000 | 46,538,000 | 2.02% | 0.00% |
| June 14, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | A | Common Stock | 10000 | $0.00 | 29,053.0000 | 46,538,000 | 52.49% | 0.02% |
| June 14, 2023 | STACK DAVID M | CEO and Chairman | A | Stock Option (Right to Buy) | 245400 | $0.00 | 245,400.0000 | 46,538,000 | 9999.99% | 0.53% |
| June 14, 2023 | STACK DAVID M | CEO and Chairman | A | Common Stock | 32700 | $0.00 | 302,665.0000 | 46,538,000 | 12.11% | 0.07% |
| June 14, 2023 | Williams Kristen Marie | Chief Administrative Officer | A | Stock Option (Right to Buy) | 27500 | $0.00 | 27,500.0000 | 46,538,000 | 9999.99% | 0.06% |
| June 14, 2023 | Williams Kristen Marie | Chief Administrative Officer | S | Common Stock | 6467 | $37.03 | 25,375.0000 | 46,538,000 | 20.31% | 0.01% |
| June 14, 2023 | Williams Kristen Marie | Chief Administrative Officer | A | Common Stock | 10950 | $0.00 | 31,842.0000 | 46,538,000 | 52.41% | 0.02% |
| June 14, 2023 | WINSTON ROY | Chief Medical Officer | A | Stock Option (Right to Buy) | 27500 | $0.00 | 27,500.0000 | 46,538,000 | 9999.99% | 0.06% |
| June 14, 2023 | WINSTON ROY | Chief Medical Officer | A | Common Stock | 10950 | $0.00 | 52,306.0000 | 46,538,000 | 26.48% | 0.02% |
| June 8, 2023 | Kronenfeld Mark A. | Director | S | Common Stock | 15000 | $37.04 | 17,897.0000 | 46,538,000 | 45.60% | 0.03% |
| June 8, 2023 | Kronenfeld Mark A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.03% |
| June 8, 2023 | Kronenfeld Mark A. | Director | M | Common Stock | 15000 | $29.90 | 32,897.0000 | 46,538,000 | 83.81% | 0.03% |
| June 6, 2023 | Ellis Ronald J. Jr. | Chief Strategy Officer | S | Common Stock | 1114 | $38.99 | 32,071.0000 | 46,538,000 | 3.36% | 0.00% |
| June 5, 2023 | Brege Laura | Director | S | Common Stock | 600 | $38.74 | 9,547.0000 | 46,538,000 | 5.91% | 0.00% |
| June 6, 2023 | Reinhart Charles A. III | Chief Financial Officer | S | Common Stock | 1236 | $38.99 | 34,997.0000 | 46,538,000 | 3.41% | 0.00% |
| June 7, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | S | Common Stock | 616 | $37.87 | 19,053.0000 | 46,538,000 | 3.13% | 0.00% |
| June 6, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | S | Common Stock | 591 | $38.99 | 19,669.0000 | 46,538,000 | 2.92% | 0.00% |
| June 7, 2023 | SLONIN JONATHAN | Chief Clinical Officer | S | Common Stock | 490 | $37.87 | 36,323.0000 | 46,538,000 | 1.33% | 0.00% |
| June 7, 2023 | REINHARDT MAX | President, Rest of World | S | Common Stock | 1099 | $37.87 | 29,225.0000 | 46,538,000 | 3.62% | 0.00% |
| June 5, 2023 | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | S | Common Stock | 2267 | $38.28 | 17,398.0000 | 46,538,000 | 11.53% | 0.00% |
| June 6, 2023 | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | S | Common Stock | 4521 | $38.55 | 12,877.0000 | 46,538,000 | 25.99% | 0.01% |
| June 6, 2023 | McLoughlin Dennis | Chief Customer Officer | S | Common Stock | 1014 | $38.99 | 39,172.0000 | 46,538,000 | 2.52% | 0.00% |
| June 7, 2023 | McLoughlin Dennis | Chief Customer Officer | S | Common Stock | 1057 | $37.87 | 38,115.0000 | 46,538,000 | 2.70% | 0.00% |
| June 5, 2023 | HASTINGS PAUL J | Director | S | Common Stock | 580 | $38.34 | 6,599.0000 | 46,538,000 | 8.08% | 0.00% |
| June 5, 2023 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 1000 | $38.74 | 23,591.0000 | 46,538,000 | 4.07% | 0.00% |
| June 6, 2023 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 1005 | $38.99 | 22,586.0000 | 46,538,000 | 4.26% | 0.00% |
| June 7, 2023 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 1047 | $37.87 | 21,539.0000 | 46,538,000 | 4.64% | 0.00% |
| June 7, 2023 | Ellis Ronald J. Jr. | Chief Strategy Officer | S | Common Stock | 1162 | $37.87 | 30,909.0000 | 46,538,000 | 3.62% | 0.00% |
| June 6, 2023 | SLONIN JONATHAN | Chief Clinical Officer | S | Common Stock | 471 | $38.99 | 36,813.0000 | 46,538,000 | 1.26% | 0.00% |
| June 7, 2023 | STACK DAVID M | CEO and Chairman | S | Common Stock | 5326 | $37.87 | 269,965.0000 | 46,538,000 | 1.93% | 0.01% |
| June 6, 2023 | STACK DAVID M | CEO and Chairman | S | Common Stock | 5058 | $38.99 | 275,291.0000 | 46,538,000 | 1.80% | 0.01% |
| June 7, 2023 | Williams Kristen Marie | Chief Administrative Officer | S | Common Stock | 1357 | $37.87 | 20,892.0000 | 46,538,000 | 6.10% | 0.00% |
| June 6, 2023 | Williams Kristen Marie | Chief Administrative Officer | S | Common Stock | 1301 | $38.99 | 22,249.0000 | 46,538,000 | 5.52% | 0.00% |
| June 7, 2023 | WINSTON ROY | Chief Medical Officer | S | Common Stock | 1857 | $37.87 | 41,356.0000 | 46,538,000 | 4.30% | 0.00% |
| June 6, 2023 | WINSTON ROY | Chief Medical Officer | S | Common Stock | 1779 | $38.99 | 43,213.0000 | 46,538,000 | 3.95% | 0.00% |
| June 6, 2023 | REINHARDT MAX | President, Rest of World | S | Common Stock | 1054 | $38.99 | 30,324.0000 | 46,538,000 | 3.36% | 0.00% |
| June 7, 2023 | Reinhart Charles A. III | Chief Financial Officer | S | Common Stock | 1371 | $37.87 | 33,626.0000 | 46,538,000 | 3.92% | 0.00% |
| May 31, 2023 | GAUGLER DARYL | Chief Operating Officer | S | Common Stock | 2500 | $39.08 | 24,591.0000 | 46,538,000 | 9.23% | 0.01% |
| May 31, 2023 | GAUGLER DARYL | Chief Operating Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.01% |
| May 31, 2023 | GAUGLER DARYL | Chief Operating Officer | M | Common Stock | 2500 | $34.00 | 26,894.0000 | 46,538,000 | 10.25% | 0.01% |
| May 15, 2023 | HASTINGS PAUL J | Director | M | Common Stock | 7000 | $29.90 | 14,179.0000 | 46,538,000 | 97.51% | 0.02% |
| May 15, 2023 | HASTINGS PAUL J | Director | S | Common Stock | 7000 | $41.85 | 7,179.0000 | 46,538,000 | 49.37% | 0.02% |
| May 15, 2023 | HASTINGS PAUL J | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.02% |
| May 11, 2023 | PACE GARY W | Director | M | Common Stock | 7000 | $29.90 | 144,690.0000 | 46,538,000 | 5.08% | 0.02% |
| May 11, 2023 | PACE GARY W | Director | S | Common Stock | 5015 | $41.78 | 139,675.0000 | 46,538,000 | 3.47% | 0.01% |
| May 11, 2023 | PACE GARY W | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.02% |
| April 3, 2023 | Brege Laura | Director | M | Common Stock | 7000 | $29.90 | 17,147.0000 | 46,538,000 | 68.99% | 0.02% |
| April 3, 2023 | Brege Laura | Director | S | Common Stock | 7000 | $40.72 | 10,147.0000 | 46,538,000 | 40.82% | 0.02% |
| April 3, 2023 | Brege Laura | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.02% |
| Jan. 5, 2023 | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | S | Common Stock | 546 | $38.31 | 19,450.0000 | 46,538,000 | 2.73% | 0.00% |
| Jan. 4, 2023 | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | S | Common Stock | 158 | $39.09 | 19,996.0000 | 46,538,000 | 0.78% | 0.00% |